NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

28 hedge funds and large institutions have $410K invested in Navidea Biopharmaceuticals Inc. in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
7
Closed
3
Calls
$3K
Puts
$4K
Net Calls
-$1K
Net Calls Change
+$37K

Top Buyers

1
WAM
1
Warberg Asset Management
Illinois
$33.9K
2
Citadel Advisors
2
Citadel Advisors
Florida
$19.7K
3
ACM
3
Allred Capital Management
Texas
$23.2K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$14K
5
TSS
5
Two Sigma Securities
New York
$4.44K

Top Sellers

1
Group One Trading
1
Group One Trading
Illinois
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$140K
4
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$0
5
VF
5
Virtu Financial
New York
$7K
Name Holding Trade Value Shares
Change 		Shares
Change %
KFS
26
Kelly Financial Services
Massachusetts
$11 – – –
BCMLT
27
Beacon Capital Management LLC (Tennessee)
Tennessee
$2 – – –
Group One Trading
28
Group One Trading
Illinois
– -$48K -190,752 Closed
Millennium Management
29
Millennium Management
New York
– -$10K -40,146 Closed
Hudson Bay Capital Management
30
Hudson Bay Capital Management
Connecticut
– -$3K -11,110 Closed
1
2